Medicine information
Uses & overview
GLICLAGLAZE TRIO 40/0.3 is a combination antidiabetic tablet marketed by Steris Healthcare. It contains Gliclazide IP 40 mg, Metformin Hydrochloride IP 500 mg, and Voglibose IP 0.3 mg. These three active ingredients work through complementary mechanisms to support blood glucose management in adults with type 2 diabetes mellitus when prescribed by a qualified healthcare professional. Gliclazide belongs to the sulfonylurea class and helps stimulate insulin release from the pancreas. Metformin Hydrochloride helps reduce glucose production in the liver and improves the body's response to insulin. Voglibose is an alpha-glucosidase inhibitor that slows the digestion and absorption of carbohydrates in the intestine, helping manage post-meal blood glucose levels. This triple-combination formulation may be considered when multiple medicines are required to help achieve individualized blood glucose targets. Treatment should be accompanied by a suitable diet, regular physical activity, and blood glucose monitoring as recommended by the treating physician. GLICLAGLAZE TRIO 40/0.3 should be used only under medical supervision. The appropriate dosage and treatment plan depend on the patient's blood glucose levels, medical history, kidney function, and response to therapy.
How to use
Take GLICLAGLAZE TRIO 40/0.3 exactly as prescribed by your doctor. Follow the recommended dosage and meal-related instructions provided by your healthcare professional and the product packaging. Voglibose is generally taken immediately before meals, but the timing of this combination tablet should follow the approved product instructions and your doctor's advice. Swallow the tablet with water as directed. Do not change the prescribed dose or discontinue treatment without consulting your doctor. Maintain a balanced diet, follow your recommended exercise routine, and monitor your blood glucose as advised. Contact your healthcare professional if you experience repeated low blood sugar episodes, persistent gastrointestinal discomfort, or other unexpected side effects.
Storage
Store GLICLAGLAZE TRIO 40/0.3 according to the instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children. Do not use the tablets after their expiry date. Dispose of unused or expired medicine responsibly according to local pharmaceutical disposal guidance.
